A leader who elevates people and challenges limits.Reshema Kemps-Polanco is Executive Vice President and US Head, Novartis Oncology, responsible for a portfolio of $7 billion and more than 15 medicines, including complex platforms such as cell and gene therapy, and radiopharmaceuticals.Reshema is inspired by reimagining cancer care through therapies that improve survival and survivorship. She is committed to decreasing healthcare inequities in screening and diagnosis and creating equal access to medicines for all patients.Reshema returned to Novartis in 2021 after spending seven years at Johnson and Joh...read more